mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.1 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |